Press release
Acanthamoeba Keratitis Market Size, Epidemiology, Pipeline, Therapies, Companies and Competitive Analysis by DelveInsight
Acanthamoeba Keratitis Market
DelveInsight's "Acanthamoeba Keratitis Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Acanthamoeba Keratitis, historical and forecasted epidemiology as well as the Acanthamoeba Keratitis market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
To know more about the Acanthamoeba Keratitis Market Report, Click here: https://www.delveinsight.com/report-store/acanthamoeba-keratitis-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr
Some facts of Acanthamoeba Keratitis Market are:
• As per a study conducted by Abelson et al. (2008), an estimated 5,000 cases of Acanthamoeba keratitis have occurred in the United States as of 2006, but since AK is so commonly misdiagnosed and the disease does not need to be reported to the Centers for Disease Control and Prevention, the actual number could be much higher. Approximately 88% of contact lens-related AK cases occur in soft contact lens wearers and 12% in rigid lens wearers.
• According to the studies it has been estimated that the disease affect male and female equally.
• According to Kozak et al. (2020), over 80% of Acanthamoeba keratitis appears in contact lens wearers. In one study, 75% of the patients were contact lens wearers; 40% wore daily soft lenses, 22% wore rigid gas permeable lenses, and 38% wore extended wear or other lenses.
• According to Booton et al. (2009), the genotype of 15 Acanthamoeba sp. isolates from AK cases from this outbreak using sequence analysis of a region of the 18S rDNA were determined. The results indicated that the isolates were predominantly genotype T4 (87%), with the remaining isolates being genotype T3 (13%). Both genotypes had previously been observed in AK cases.
Request for Free Sample Report: https://www.delveinsight.com/sample-request/acanthamoeba-keratitis-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr
Scope of the Acanthamoeba Keratitis Market Report
• The report covers the descriptive overview of Acanthamoeba Keratitis, explaining its causes, signs and symptoms, pathophysiology, diagnosis and currently available therapies.
• Comprehensive insight has been provided into the Acanthamoeba Keratitis epidemiology and treatment in the 7MM.
• Additionally, an all-inclusive account of both the current and emerging therapies for Acanthamoeba Keratitis is provided, along with the assessment of new therapies, which will have an impact on the current treatment landscape.
• A detailed review of the Acanthamoeba Keratitis market; historical and forecasted is included in the report, covering drug outreach in the 7MM.
• The report provides an edge while developing business strategies, by understanding trends shaping and driving the global Acanthamoeba Keratitis market.
Some of the Acanthamoeba Keratitis Companies are:
• Polihexanide (PHMB)
• And Others
To know more about the Acanthamoeba Keratitis Therapies and Companies, Click here: https://www.delveinsight.com/report-store/acanthamoeba-keratitis-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr
Acanthamoeba Keratitis Drugs:
• SIFI
• And Others
Request for Free Sample Report: https://www.delveinsight.com/sample-request/acanthamoeba-keratitis-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr
Table of Contents:
1. Key Insights
2. Executive Summary of Acanthamoeba Keratitis
3. Competitive Intelligence Analysis for Acanthamoeba Keratitis
4. Acanthamoeba Keratitis: Market Overview at a Glance
5. Acanthamoeba Keratitis: Disease Background and Overview
5.1. Introduction
8. Treatment Algorithm, Current Treatment, and Medical Practices
9. Unmet Needs
10. Key Endpoints of Acanthamoeba Keratitis Treatment
11. Marketed Products
List to be continued in report
12. Emerging Therapies
List to be continued in report
13. Acanthamoeba Keratitis: Seven Major Market Analysis
14. Attribute analysis
15. 7MM: Market Outlook
16. Access and Reimbursement Overview of Acanthamoeba Keratitis
17. KOL Views
18. Market Drivers
19. Market Barriers
20. Appendix
20.1. Bibliography
20.2. Report Methodology
21. DelveInsight Capabilities
22. Disclaimer
23. About DelveInsight
To get access to free Acanthamoeba Keratitis Research Report, Click here: https://www.delveinsight.com/report-store/acanthamoeba-keratitis-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr
Latest Reports by DelveInsight
Basal Cell Carcinoma Market
https://www.delveinsight.com/report-store/basal-cell-carcinoma-basal-cell-epithelioma-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr
Birch Allergy Market
https://www.delveinsight.com/report-store/birch-allergy-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr
Bile Duct Neoplasm Market
https://www.delveinsight.com/report-store/bile-duct-neoplasms-epidemiology-forecast?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr
Gingivitis Market
https://www.delveinsight.com/report-store/gingivitis-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr
Lupus Nephritis Market
https://www.delveinsight.com/report-store/lupus-nephritis-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr
Severe Hypertriglyceridemia (SHTG) Market
https://www.delveinsight.com/report-store/severe-hypertriglyceridemia-shtg-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr
Arthralgia Market
https://www.delveinsight.com/report-store/arthralgia-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr
Primordial Dwarfism Market
https://www.delveinsight.com/report-store/primordial-dwarfism-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr
Non-Cystic Fibrosis Bronchiectasis Market
https://www.delveinsight.com/report-store/non-cystic-fibrosis-bronchiectasis-ncfb-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr
Microsatellite Stable Colorectal Cancer Market
https://www.delveinsight.com/report-store/microsatellite-stable-colorectal-cancer-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr
Chondrosarcoma Market
https://www.delveinsight.com/report-store/chondrosarcoma-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr
Sialidosis Market
https://www.delveinsight.com/report-store/sialidosis-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr
Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Ankit Nigam
Email: info@delveinsight.com
Phone: +19193216187
City: Albany
State: New York
Country: United States
To know more about the Acanthamoeba Keratitis Market Report, Click here: https://www.delveinsight.com/report-store/acanthamoeba-keratitis-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr
428, D21 Corporate Park, Sector-21, Dwarka, New Delhi-110077, India
About DelveInsight
DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing end-to-end comprehensive solutions to improve their performance.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Acanthamoeba Keratitis Market Size, Epidemiology, Pipeline, Therapies, Companies and Competitive Analysis by DelveInsight here
News-ID: 2681416 • Views: …
More Releases from DelveInsight Business Research
Panic Disorder Market Forecast 2032: Rising Global Prevalence and Emerging Thera …
DelveInsight's "Panic Disorder Market Insights, Epidemiology, and Market Forecast-2032" report delivers a comprehensive evaluation of Panic Disorder, covering historical data, current trends, and future projections across major global markets, including the United States, EU4 (Germany, France, Italy, and Spain), the United Kingdom, and Japan.
This latest healthcare market forecast offers an extensive assessment of the Panic Disorder landscape, providing detailed insights into revenue patterns, disease prevalence, and evolving treatment approaches. The…
Catheter-related Bloodstream Infection (CRBSI) Pipeline Therapies Analysis 2025: …
DelveInsight's analysis highlights that the Catheter-related Bloodstream Infection (CRBSI) pipeline features over five leading companies actively advancing more than five therapeutic candidates aimed at improving CRBSI management.
DelveInsight's "CRBSI Pipeline Insight 2025" report delivers an in-depth evaluation of ongoing clinical research activities and future growth opportunities within the CRBSI therapeutics landscape.
The Surgical Site Infections Pipeline report offers comprehensive clinical and commercial insights into pipeline candidates ranging from preclinical and discovery stages…
Hepatitis C Virus (HCV) Infection Pipeline Therapies 2025: Over 20 Companies Dri …
According to DelveInsight's evaluation, the global Hepatitis C Virus (HCV) Infection pipeline features more than 20 prominent pharmaceutical and biotechnology companies actively engaged in the development of over 20+ therapeutic candidates. The analysis spans clinical trial activity, therapeutic approaches, mechanisms of action, routes of administration, and recent developments shaping the Hepatitis C Virus Infection treatment landscape.
The "Hepatitis C Virus Infection Pipeline Insight, 2025" report published by DelveInsight delivers an in-depth…
Surgical Site Infections Pipeline Therapies Analysis 2025: Over 5 Companies Driv …
Surgical Site Infections Pipeline Insight 2025: Over 5 Companies Driving Innovation Across 5+ Therapies | DelveInsight
(Albany, United States) According to DelveInsight's analysis, the global Surgical Site Infections pipeline includes more than 5 leading companies actively engaged in the development of over 5 potential SSI therapies. The report provides detailed analysis across clinical trials, therapeutic approaches, mechanisms of action, routes of administration, and recent developmental activities.
DelveInsight's "Surgical Site Infections Pipeline Insight,…
More Releases for Acanthamoeba
Thrombocytopenia Market is expected to reach USD 12.5 billion by 2034
Thrombocytopenia is a condition characterized by low platelet counts in the blood, which increases the risk of bleeding and can be caused by a range of factors, including autoimmune disorders, bone marrow diseases, and certain medications. The condition can vary in severity, from mild cases that require minimal intervention to severe cases that may require urgent treatment and even platelet transfusions.
Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/71453
With…
Acanthamoeba Keratitis Market Dynamics Indicate Upward Trajectory Through 2034, …
The Acanthamoeba Keratitis market is expected to surge due to the disease's increasing prevalence and awareness during the forecast period. Furthermore, launching various multiple-stage Acanthamoeba Keratitis pipeline products will significantly revolutionize the Acanthamoeba Keratitis market dynamics.
DelveInsight's "Acanthamoeba Keratitis Market Insights, Epidemiology, and Market Forecast-2034′′ report offers an in-depth understanding of the Acanthamoeba Keratitis, historical and forecasted epidemiology as well as the Acanthamoeba Keratitis market trends in the United…
Acanthamoeba Keratitis market is expected to reach USD 382 million by 2034
Acanthamoeba keratitis (AK) is a rare but severe eye infection caused by Acanthamoeba species, leading to corneal inflammation, severe pain, and potential vision loss if untreated. Although rare, the disease has gained importance due to increasing contact lens usage, which represents the major risk factor for AK. Early diagnosis and effective treatment are critical for preserving vision, but management remains challenging due to the infection's resistance to conventional drugs.
Download Full…
Acanthamoeba Keratitis Market Poised for Significant Growth from 2023 to 2032, R …
The Acanthamoeba Keratitis Market Forecast report offers an in-depth understanding of the Acanthamoeba Keratitis, historical and forecasted epidemiology as well as the Acanthamoeba Keratitis market trends in the 7MM.
The Acanthamoeba Keratitis market is expected to surge due to the disease's increasing prevalence and awareness during the forecast period. Furthermore, launching various multiple-stage Acanthamoeba Keratitis pipeline products will significantly revolutionize the Acanthamoeba Keratitis market dynamics.
DelveInsight's "Acanthamoeba Keratitis Market Insights, Epidemiology, and…
Acanthamoeba Keratitis Market Forecast 2032: FDA, EMA and PDMA Approvals, Epidem …
Acanthamoeba Keratitis companies are Allergan, Merck Sharp & Dohme, Pfizer Inc., GlaxoSmithKline plc, SIFI SpA, Cipla Inc., AstraZeneca, Johnson & Johnson Private Limited, Basilea Pharmaceutica Ltd., Tetraphase Pharmaceuticals, Abbott, Roche, Mylan N.V., Teva Pharmaceutical Industries Ltd., Sanofi, Novartis AG, Bayer AG, Lilly, Aurobindo Pharma, Lupin, SHIONOGI & Co, AbbVie Inc , and others
(New York, USA) DelveInsight's "Acanthamoeba Keratitis Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of…
Acanthamoeba Keratitis Market is Expected to Expand at a Healthy Growth Rate Dur …
The Acanthamoeba Keratitis market is expected to surge due to the disease's increasing prevalence and awareness during the forecast period. Furthermore, launching various multiple-stage Acanthamoeba Keratitis pipeline products will significantly revolutionize the Acanthamoeba Keratitis market dynamics.
DelveInsight's "Acanthamoeba Keratitis Market Insights, Epidemiology, and Market Forecast-2032″ report offers an in-depth understanding of the Acanthamoeba Keratitis, historical and forecasted epidemiology as well as the Acanthamoeba Keratitis market trends in the United…
